kyvero
Market leaders

RDNT

RadNet, Inc. (RDNT)

Healthcare • Diagnostics & Research

StockNasdaqGMUnited StatesUS7504911022

76.00 USD -0.05% today Updated 13 Nov 2026 16:26

Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by RadNet, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.

Price history

Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.

All time

Updated 13 Nov 2026 16:26. Information, not advice. Showing the last 12 months. Create a free account to see the whole history

Results

Next results 25 Feb 2027 in 104 days · 16:00 · estimate 0.22
Last results 0.30 vs 0.22 estimated 08 Nov 2026 · Beat +35.5%
Beat the estimate 8 of 12 4 missed · 0 in line · 2 beats in a row
Average surprise +111.4% reported against the estimate, last 12 quarters

Earnings per share: estimate and reported

29 Feb 2024: estimate 0.13 29 Feb 2024: reported 0.20 02/24 08 May 2024: estimate 0.01 08 May 2024: reported 0.07 05/24 07 Aug 2024: estimate 0.17 07 Aug 2024: reported 0.16 08/24 10 Nov 2024: estimate 0.17 10 Nov 2024: reported 0.18 11/24 27 Feb 2025: estimate 0.19 27 Feb 2025: reported 0.22 02/25 11 May 2025: estimate -0.13 11 May 2025: reported -0.35 05/25 10 Aug 2025: estimate 0.16 10 Aug 2025: reported 0.31 08/25 09 Nov 2025: estimate 0.23 09 Nov 2025: reported 0.20 11/25 02 Mar 2026: estimate 0.20 02 Mar 2026: reported 0.23 03/26 10 May 2026: estimate -0.19 10 May 2026: reported -0.28 05/26 09 Aug 2026: estimate 0.20 09 Aug 2026: reported 0.29 08/26 08 Nov 2026: estimate 0.22 08 Nov 2026: reported 0.30 11/26

Estimate Reported: beat Reported: miss In line

Quarterly results

DateEPS estimateEPS reportedSurpriseResult
25 Feb 2027 16:00 0.22 — — Upcoming
08 Nov 2026 16:00 0.22 0.30 +35.5% Beat
09 Aug 2026 16:00 0.20 0.29 +44.0% Beat
10 May 2026 16:00 -0.19 -0.28 -46.1% Miss
02 Mar 2026 06:00 0.20 0.23 +12.6% Beat
09 Nov 2025 16:00 0.23 0.20 -11.8% Miss
10 Aug 2025 16:00 0.16 0.31 +97.9% Beat
11 May 2025 16:00 -0.13 -0.35 -166.8% Miss
27 Feb 2025 16:00 0.19 0.22 +17.3% Beat
10 Nov 2024 16:00 0.17 0.18 +5.9% Beat
07 Aug 2024 16:00 0.17 0.16 -8.1% Miss
08 May 2024 16:00 0.01 0.07 +1,300.0% Beat
29 Feb 2024 16:00 0.13 0.20 +56.3% Beat
08 Nov 2023 16:00 0.07 0.14 +89.2% Beat
08 Aug 2023 06:00 0.10 0.24 +152.6% Beat
09 May 2023 06:00 -0.08 -0.08 0.0% In line
01 Mar 2023 14:00 0.15 0.11 -25.0% Miss
09 Nov 2022 06:00 0.16 0.09 -43.0% Miss
09 Aug 2022 06:00 0.09 0.15 +71.4% Beat
09 May 2022 06:00 — -0.15 -4,604.5% Miss
01 Mar 2022 06:00 0.19 0.13 -30.7% Miss
08 Nov 2021 06:00 0.18 0.21 +18.3% Beat
09 Aug 2021 06:00 0.14 0.27 +88.4% Beat
10 May 2021 06:00 -0.04 0.04 +209.1% Beat
08 Mar 2021 06:00 0.15 0.20 +36.4% Beat
09 Nov 2020 06:00 -0.12 0.15 +225.0% Beat
10 Aug 2020 16:00 -0.51 -0.14 +72.6% Beat
11 May 2020 12:00 -0.29 -0.31 -6.9% Miss
12 Mar 2020 06:00 0.15 0.21 +43.2% Beat
12 Nov 2019 06:00 0.12 0.08 -34.6% Miss
09 Aug 2019 13:00 0.14 0.10 -22.6% Miss
09 May 2019 06:00 -0.06 -0.06 +7.3% Beat
14 Mar 2019 06:00 0.18 0.37 +105.7% Beat
09 Nov 2018 06:00 0.16 0.10 -36.4% Miss
09 Aug 2018 06:00 0.14 0.12 -13.3% Miss
09 May 2018 06:00 -0.07 -0.14 -104.3% Miss
08 Mar 2018 06:00 0.13 0.13 +4.0% Beat
09 Nov 2017 06:00 0.12 0.12 0.0% In line
08 Aug 2017 06:00 0.04 0.10 +145.0% Beat
10 May 2017 06:00 0.01 -0.03 -400.0% Miss
14 Mar 2017 06:00 0.11 0.11 +2.4% Beat
09 Nov 2016 06:00 0.12 0.11 -8.3% Miss
09 Aug 2016 06:00 0.05 0.09 +100.0% Beat
10 May 2016 08:00 -0.04 -0.04 0.0% In line
14 Mar 2016 06:00 0.17 0.04 -75.3% Miss
09 Nov 2015 06:00 0.18 0.12 -30.7% Miss
10 Aug 2015 06:00 0.13 0.08 -40.0% Miss
11 May 2015 06:00 0.06 -0.11 -289.5% Miss
16 Mar 2015 06:00 0.08 0.10 +24.4% Beat
06 Nov 2014 06:00 0.05 0.10 +89.6% Beat
08 Aug 2014 06:00 0.05 0.14 +171.6% Beat

Annual results · USD

YearRevenueChangeNet income Net marginEPSEPS changeFree cash flow
2025 2B +11.5% -18.7M -0.9% -0.25 -725.0% 85.6M
2024 1.8B +13.2% 2.8M 0.2% 0.04 -20.0% 45M
2023 1.6B +13.0% 3M 0.2% 0.05 -70.6% 44.3M
2022 1.4B — 10.7M 0.7% 0.17 — 27M

Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.

Prices by day, week and month

Price history in USD, by day
PeriodOpening priceHighLow Closing priceChangeVolumeDividend
13 Nov 2026 75.99 76.49 75.13 76.00 -0.05% 52,935
12 Nov 2026 78.09 78.25 75.91 76.04 -2.61% 408,000
11 Nov 2026 79.03 79.96 77.83 78.08 +0.18% 732,300
10 Nov 2026 80.86 81.00 77.16 77.94 -0.56% 661,400
09 Nov 2026 75.58 80.70 73.22 78.38 +3.13% 1,259,600
06 Nov 2026 77.21 78.13 72.49 76.00 -2.58% 1,664,300
05 Nov 2026 81.00 81.87 77.74 78.01 -2.80% 1,050,700
04 Nov 2026 75.32 80.57 74.35 80.26 +9.67% 1,727,200
03 Nov 2026 73.98 74.78 72.84 73.18 +0.11% 988,200
02 Nov 2026 73.90 75.17 73.03 73.10 -0.53% 960,700
1,250 older periods: create a free account to see the whole history

Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.

News

Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.

Key data

Previous close
76.04 USD
Market cap
6.0B
Exchange
NasdaqGM
Country
United States
Sector
Healthcare
Industry
Diagnostics & Research
Currency
USD

Dividends

No dividends on record.

Why this score

How the score is made up
Part of the scorePointsWhy
Business growth Yearly growth of revenue and of earnings per share. 21.0 / 25
  • Revenue growth of 12.6% a year
Quality Return on equity, net margin and how stable the margins are. 8.3 / 25
  • ROE of 2%
Financial strength Net debt against operating earnings, interest cover and free cash flow. 6.3 / 20
  • Net debt is 5.0× EBITDA
  • Free cash flow yield of 2.7%
Valuation Free cash flow yield and the P/E against its sector. 3.4 / 15
  • Forward P/E 85.8: it is expected to earn money
Analysts How far the analysts' average target is from today's price. 10.0 / 10
  • Analysts' target is +26% from the price
  • Score capped at 50: three or more warnings
  • Heavy debt: net debt is 5.0× EBITDA
  • Thin interest cover: operating profit is only 1.2× the interest
  • The last full year was a loss

Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A). Warnings take 18 points off.

Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio. How the score works

Figures

Valuation
FigureValueReading Sector median
P/E (forward) 85.8× Weak 14.16×
Price / book 5.49× Weak 3.5×
Price / sales 2.58× Fair 3.33×
EV / EBITDA 27.89× Weak 11.19×
Free cash flow yield 2.7% Fair 2.1%
Quality
FigureValueReading Sector median
Gross margin 16.7% Weak 54.9%
Operating margin 4.4% Weak 5.8%
Net margin -0.9% Weak 1.2%
Return on equity 1.8% Weak 4.4%
Return on assets 1.6% Weak 2.7%
Growth
FigureValueReading Sector median
Revenue growth / year 12.6% Good 10.1%
Financial health
FigureValueReading Sector median
Debt / equity 1.51× Fair 0.4×
Net debt / EBITDA 5.04× Weak 1.46×
Interest cover 1.19× Weak 2.17×
Current ratio 1.49× Fair 2.64×
Dividends
FigureValueReading Sector median
Payout of earnings 0% Weak 0%

The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.

Similar shares

Follow RDNT and get alerts

Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.

Start for free Log in